DB
CELU icon

Danske Bank’s Celularity CELU Stock Holding History

Danske Bank’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Hold
1
– – ﹤0.01% 1160
2025
Q4 		$1 Hold
1
– – ﹤0.01% 1548
2025
Q3 		$2 Hold
1
– – ﹤0.01% 1465
2025
Q2 		$2 Hold
1
– – ﹤0.01% 1496
2025
Q1 		$2 Hold
1
– – ﹤0.01% 1339
2024
Q4 		$2 Hold
1
– – ﹤0.01% 1376
2024
Q3 		$3 Buy
+1
New +$3 ﹤0.01% 1559

Other funds holding CELU

CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return

Danske Bank's CELU Position: Q1 2026 in Review

Danske Bank held its Celularity (CELU) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1160.

Danske Bank first reported a position in CELU in Q3 2024 and has held it in 7 quarters since. The position peaked at $3 in Q3 2024. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

  • Danske Bank held 1 share of Celularity worth $1 as of Q1 2026.
  • Danske Bank left its Celularity share count unchanged in Q1 2026.
  • Celularity made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #1160 holding.
  • Danske Bank first reported a position in Celularity in Q3 2024 and has held it in 7 quarters since.
  • Danske Bank's Celularity position peaked at $3 in Q3 2024.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.